New research results or upcoming events: Stay up-to-date on what is happening at TUM.
The Paralympic Winter Games are just around the corner. After her recent triumph at the World Cup, German sit-skier Anna Schaffelhuber is among the favorites to take gold. A specialist in Slalom and Giant Slalom, Schaffelhuber has been training at Technische Universität München (TUM) since 2008. Sports scientist Dr. Peter Spitzenpfeil and his team have developed a new training program tailored to the physical needs of paraplegic monoskiers.
Wacker Chemie AG and the Technische Universitaet Muenchen (TUM) are extending their existing partnership in silicon chemistry for another six years. Yesterday they signed an agreement to this effect. The Munich-based chemical Group is sponsoring the Institute of Silicon Chemistry, located on the research campus in Garching near Munich, with a total of up to €2.5 million. This will finance doctoral positions and the associated material resources. WACKER and the TUM founded the Institute of Silicon Chemistry in 2006. Over recent years, more than 30 research projects have been conducted, which have resulted in ten patents and 35 scientific publications in international journals.
Tau proteins, which are responsible for Alzheimer’s disease, bind to the folding protein Hsp90. The molecular recognition mechanisms that play a role here, have been unveiled by an international team of scientists led by the Technische Universitaet Muenchen (TUM) and the Helmholtz Zentrum Muenchen. This might open the door for new approaches for the treatment of Alzheimer’s disease, as the scientists report in the trade journal “Cell”.
The Technology and Management (TUM-BWL) course has become the first German bachelor degree program to obtain the prestigious EPAS quality seal. The European Foundation for Management Development (EFMD) awards accreditation to business management degree programs of outstanding quality with international orientation. TUM-BWL combines education in management with a technical or science degree and optimally prepares students for international activities.
Scientists from the Technische Universitaet Muenchen and the Helmholtz Zentrum München have discovered how the viral DNA of the hepatitis B virus (HBV) can be degraded in the cell nucleus of liver cells, consequently allowing the virus to be eliminated. Viruses such as HBV can persist by depositing their genetic information (DNA) in the cell nucleus, where the DNA is normally not degraded. This prevents antiviral drugs from eliminating these viruses. But the newly discovered mechanism could make this possible without damaging the infected cell in the liver. In the current issue of the prestigious journal "Science", the scientists report that now new therapeutic possibilities are consequently opening up.
In the future, an entire chemistry lab could be accommodated in a tiny little droplet. While simple reactions already work in these simplest models of an artificial cell now a group of scientists of the Cluster of Excellence Nanosystems Initiative Munich (NIM) have established and investigated for the first time a complex biochemical system. They discovered a surprising diversity.
Proteases are vital proteins that serve for order within cells. They break apart other proteins, ensuring that these are properly synthesized and decomposed. Proteases are also responsible for the pathogenic effects of many kinds of bacteria. Now chemists at the Technische Universitaet Muenchen (TUM) have discovered two hitherto unknown mechanisms of action that can be used to permanently disarm an important bacterial protease.
Scientists at the Techinsche Universität München (TUM) have developed a new racing sled for the skeleton rider Anja Huber. The twofold world champion will take part in the Olympic Games in Sotchi using the ergonomically and aerodynamically optimized sled.
Among all of the German universities, the Technische Universität München (TUM) has won the largest amount of research funding from the just-expired Seventh Framework Program (FP7) of the EU, with a total of more than 130 million euros. The latest success: Two TUM scientists have received ERC Consolidator Grants, each of which provides around two million euros in funding. Dr. Wilhelm Auwärter is a group leader in Molecular Nanoscience and Chemical Physics of Interfaces. Prof. Thomas Misgeld leads the laboratory for Biomolecular Sensors, where he investigates the degeneration of nerve fibers.
Stem cells can turn into heart cells, skin cells can mutate to cancer cells; even cells of the same tissue type exhibit small heterogeneities. Scientists use single-cell analysis to investigate these heterogeneities. But the method is still laborious and considerable inaccuracies conceal smaller effects. Scientists at the Technische Universitaet Muenchen (TUM), the Helmholtz Zentrum Muenchen and the University of Virginia (USA) have now found a way to simplify and improve the analysis by mathematical methods.